Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)
Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.
Gespeichert in:
Veröffentlicht in: | Clinical genitourinary cancer 2016-04, Vol.14 (2), p.e153-e159 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e159 |
---|---|
container_issue | 2 |
container_start_page | e153 |
container_title | Clinical genitourinary cancer |
container_volume | 14 |
creator | Bamias, Aristotle Peroukidis, Stavros Stamatopoulou, Sophia Tzannis, Kimon Koutsoukos, Konstantinos Andreadis, Charalambos Bozionelou, Vasiliki Pistalmatzian, Nikos Papatsoris, Athanasios Stravodimos, Konstantinos Varthalitis, Ioannis Karamouzis, Michalis Milaki, Georgia Agorastos, Antonios Kentepozidis, Nikos Androulakis, Nikos Bompolaki, Iliada Kalofonos, Haralampos Mavroudis, Dimitrios Dimopoulos, Meletios A |
description | Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease. |
doi_str_mv | 10.1016/j.clgc.2015.09.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1772143805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1558767315002505</els_id><sourcerecordid>1772143805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</originalsourceid><addsrcrecordid>eNp9UsuO1DAQjBCIXRZ-gAPycTkktPM2QiuNIsggrYTEMGfLcdqsByce7GSk8Cl8LQ4zcODAxY9WddlV1VH0kkJCgZZvDok0X2WSAi0SYAkAexRdU5bVMZR1-jici6KOq7LKrqJn3h8A8oJW8DS6Sss8qxiw6-jnftJG_xCTtiOxiuwWP-GgJWkecLDTAzpxXIgeyaY_iVFiT_ZuLRstDGnWintLNuQzTs76I8pJn5A01hjRWSd-33bT3C-kW0hoI1s0BsfA34Z1srPTo3DLhYm0zs5Hcrtt9037-nn0RAnj8cVlv4n2H95_abbx_af2Y7O5j2VO6RTnRQldX0vWqTxXsq-LTmW1UErRuqiQ5iizkgUrOlUzBZApBp2ss2CXqliVZzfR7Zn36Oz3Gf3EB-1l-KcY0c6e06pKaZ7VUARoeobKoNY7VPzo9BAEcAp8zYQf-JoJXzPhwHh4JDS9uvDP3YD935Y_IQTAuzMAg8qTRse91LiarV1wlPdW_5__7p92aXSwWJhvuKA_BJPH4B-n3Kcc-G6dinUoaAGQFkHVL-vktBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1772143805</pqid></control><display><type>article</type><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</creator><creatorcontrib>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</creatorcontrib><description>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</description><identifier>ISSN: 1558-7673</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2015.09.009</identifier><identifier>PMID: 26437909</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Advanced urothelial cancer ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cisplatin - therapeutic use ; Female ; Fitness for cisplatin ; Greece ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Middle Aged ; Patterns of practice ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Factors ; Survival Analysis ; Treatment Outcome ; Urologic Neoplasms - drug therapy ; Urologic Neoplasms - pathology ; Urology ; Urothelium - pathology</subject><ispartof>Clinical genitourinary cancer, 2016-04, Vol.14 (2), p.e153-e159</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</citedby><cites>FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</cites><orcidid>0000-0002-1710-125X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26437909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bamias, Aristotle</creatorcontrib><creatorcontrib>Peroukidis, Stavros</creatorcontrib><creatorcontrib>Stamatopoulou, Sophia</creatorcontrib><creatorcontrib>Tzannis, Kimon</creatorcontrib><creatorcontrib>Koutsoukos, Konstantinos</creatorcontrib><creatorcontrib>Andreadis, Charalambos</creatorcontrib><creatorcontrib>Bozionelou, Vasiliki</creatorcontrib><creatorcontrib>Pistalmatzian, Nikos</creatorcontrib><creatorcontrib>Papatsoris, Athanasios</creatorcontrib><creatorcontrib>Stravodimos, Konstantinos</creatorcontrib><creatorcontrib>Varthalitis, Ioannis</creatorcontrib><creatorcontrib>Karamouzis, Michalis</creatorcontrib><creatorcontrib>Milaki, Georgia</creatorcontrib><creatorcontrib>Agorastos, Antonios</creatorcontrib><creatorcontrib>Kentepozidis, Nikos</creatorcontrib><creatorcontrib>Androulakis, Nikos</creatorcontrib><creatorcontrib>Bompolaki, Iliada</creatorcontrib><creatorcontrib>Kalofonos, Haralampos</creatorcontrib><creatorcontrib>Mavroudis, Dimitrios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios A</creatorcontrib><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><description>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</description><subject>Advanced urothelial cancer</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cisplatin - therapeutic use</subject><subject>Female</subject><subject>Fitness for cisplatin</subject><subject>Greece</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patterns of practice</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Urologic Neoplasms - drug therapy</subject><subject>Urologic Neoplasms - pathology</subject><subject>Urology</subject><subject>Urothelium - pathology</subject><issn>1558-7673</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsuO1DAQjBCIXRZ-gAPycTkktPM2QiuNIsggrYTEMGfLcdqsByce7GSk8Cl8LQ4zcODAxY9WddlV1VH0kkJCgZZvDok0X2WSAi0SYAkAexRdU5bVMZR1-jici6KOq7LKrqJn3h8A8oJW8DS6Sss8qxiw6-jnftJG_xCTtiOxiuwWP-GgJWkecLDTAzpxXIgeyaY_iVFiT_ZuLRstDGnWintLNuQzTs76I8pJn5A01hjRWSd-33bT3C-kW0hoI1s0BsfA34Z1srPTo3DLhYm0zs5Hcrtt9037-nn0RAnj8cVlv4n2H95_abbx_af2Y7O5j2VO6RTnRQldX0vWqTxXsq-LTmW1UErRuqiQ5iizkgUrOlUzBZApBp2ss2CXqliVZzfR7Zn36Oz3Gf3EB-1l-KcY0c6e06pKaZ7VUARoeobKoNY7VPzo9BAEcAp8zYQf-JoJXzPhwHh4JDS9uvDP3YD935Y_IQTAuzMAg8qTRse91LiarV1wlPdW_5__7p92aXSwWJhvuKA_BJPH4B-n3Kcc-G6dinUoaAGQFkHVL-vktBA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Bamias, Aristotle</creator><creator>Peroukidis, Stavros</creator><creator>Stamatopoulou, Sophia</creator><creator>Tzannis, Kimon</creator><creator>Koutsoukos, Konstantinos</creator><creator>Andreadis, Charalambos</creator><creator>Bozionelou, Vasiliki</creator><creator>Pistalmatzian, Nikos</creator><creator>Papatsoris, Athanasios</creator><creator>Stravodimos, Konstantinos</creator><creator>Varthalitis, Ioannis</creator><creator>Karamouzis, Michalis</creator><creator>Milaki, Georgia</creator><creator>Agorastos, Antonios</creator><creator>Kentepozidis, Nikos</creator><creator>Androulakis, Nikos</creator><creator>Bompolaki, Iliada</creator><creator>Kalofonos, Haralampos</creator><creator>Mavroudis, Dimitrios</creator><creator>Dimopoulos, Meletios A</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1710-125X</orcidid></search><sort><creationdate>20160401</creationdate><title>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</title><author>Bamias, Aristotle ; Peroukidis, Stavros ; Stamatopoulou, Sophia ; Tzannis, Kimon ; Koutsoukos, Konstantinos ; Andreadis, Charalambos ; Bozionelou, Vasiliki ; Pistalmatzian, Nikos ; Papatsoris, Athanasios ; Stravodimos, Konstantinos ; Varthalitis, Ioannis ; Karamouzis, Michalis ; Milaki, Georgia ; Agorastos, Antonios ; Kentepozidis, Nikos ; Androulakis, Nikos ; Bompolaki, Iliada ; Kalofonos, Haralampos ; Mavroudis, Dimitrios ; Dimopoulos, Meletios A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-4560bd8c9bf44fcd85bf38afff1857e14ec369155bf89f003f90bc83009f79743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Advanced urothelial cancer</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cisplatin - therapeutic use</topic><topic>Female</topic><topic>Fitness for cisplatin</topic><topic>Greece</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patterns of practice</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Urologic Neoplasms - drug therapy</topic><topic>Urologic Neoplasms - pathology</topic><topic>Urology</topic><topic>Urothelium - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bamias, Aristotle</creatorcontrib><creatorcontrib>Peroukidis, Stavros</creatorcontrib><creatorcontrib>Stamatopoulou, Sophia</creatorcontrib><creatorcontrib>Tzannis, Kimon</creatorcontrib><creatorcontrib>Koutsoukos, Konstantinos</creatorcontrib><creatorcontrib>Andreadis, Charalambos</creatorcontrib><creatorcontrib>Bozionelou, Vasiliki</creatorcontrib><creatorcontrib>Pistalmatzian, Nikos</creatorcontrib><creatorcontrib>Papatsoris, Athanasios</creatorcontrib><creatorcontrib>Stravodimos, Konstantinos</creatorcontrib><creatorcontrib>Varthalitis, Ioannis</creatorcontrib><creatorcontrib>Karamouzis, Michalis</creatorcontrib><creatorcontrib>Milaki, Georgia</creatorcontrib><creatorcontrib>Agorastos, Antonios</creatorcontrib><creatorcontrib>Kentepozidis, Nikos</creatorcontrib><creatorcontrib>Androulakis, Nikos</creatorcontrib><creatorcontrib>Bompolaki, Iliada</creatorcontrib><creatorcontrib>Kalofonos, Haralampos</creatorcontrib><creatorcontrib>Mavroudis, Dimitrios</creatorcontrib><creatorcontrib>Dimopoulos, Meletios A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bamias, Aristotle</au><au>Peroukidis, Stavros</au><au>Stamatopoulou, Sophia</au><au>Tzannis, Kimon</au><au>Koutsoukos, Konstantinos</au><au>Andreadis, Charalambos</au><au>Bozionelou, Vasiliki</au><au>Pistalmatzian, Nikos</au><au>Papatsoris, Athanasios</au><au>Stravodimos, Konstantinos</au><au>Varthalitis, Ioannis</au><au>Karamouzis, Michalis</au><au>Milaki, Georgia</au><au>Agorastos, Antonios</au><au>Kentepozidis, Nikos</au><au>Androulakis, Nikos</au><au>Bompolaki, Iliada</au><au>Kalofonos, Haralampos</au><au>Mavroudis, Dimitrios</au><au>Dimopoulos, Meletios A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>14</volume><issue>2</issue><spage>e153</spage><epage>e159</epage><pages>e153-e159</pages><issn>1558-7673</issn><eissn>1938-0682</eissn><abstract>Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26437909</pmid><doi>10.1016/j.clgc.2015.09.009</doi><orcidid>https://orcid.org/0000-0002-1710-125X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1558-7673 |
ispartof | Clinical genitourinary cancer, 2016-04, Vol.14 (2), p.e153-e159 |
issn | 1558-7673 1938-0682 |
language | eng |
recordid | cdi_proquest_miscellaneous_1772143805 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Advanced urothelial cancer Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cisplatin - therapeutic use Female Fitness for cisplatin Greece Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Patterns of practice Prognosis Recurrence Retrospective Studies Risk Factors Survival Analysis Treatment Outcome Urologic Neoplasms - drug therapy Urologic Neoplasms - pathology Urology Urothelium - pathology |
title | Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20Systemic%20Chemotherapy%20in%20Advanced%20Urothelial%20Cancer:%20A%20Retrospective%20Collaborative%20Study%20by%20the%20Hellenic%20Genitourinary%20Cancer%20Group%20(HGUCG)&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Bamias,%20Aristotle&rft.date=2016-04-01&rft.volume=14&rft.issue=2&rft.spage=e153&rft.epage=e159&rft.pages=e153-e159&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2015.09.009&rft_dat=%3Cproquest_cross%3E1772143805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1772143805&rft_id=info:pmid/26437909&rft_els_id=S1558767315002505&rfr_iscdi=true |